Table 2.

The effect of treatment on clinical parameters in patients with IgAN.

	Before treatment	After treatment
Age, years	40(26–58)	40 (26–58)
Female/Male	4/2	4/2
Serum IgA, g/L	3.26 (1.79–4.88)	3.09 (2.18–3.75)
Urinary protein, g/24 h	5.19 (0.98–9.50)	2.61 (0.47–5.54)*
Serum uric acid, μmol/L	381 (326–451)	369.83 (217–431)
Triglycerides, mmol/L	1.85 (0.90–3.12)	1.79 (1.12–2.98)
Cholesterol, mmol/L	6.92 (2.80–9.95)	5.85 (2.67–8.33)
eGFR, mL/min/1.73 m2	66.89 (32.1–119)	86.83 (41.3–115)*
serum albumin, g/L	24.8 (12.1–31)	31.72 (27.3–40.6)
WBC, 109/L	6.44 (4.96–8.12)	6.79 (5.37–8.44)
Lymphocytes, 109/L	1.56 (1.21–2.58)	1.49 (0.37–2.34)

Data are present as median (range). *P < 0.05 vs. the values before treatment.